Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Promise and Progress - New Appointments and Arrivals

Leading the Way Fall 2009 Winter 2010

New Appointments and Arrivals

By: Valerie Mehl
Date: December 1, 2009


Carol Greider, Ph.D., Daniel Nathans Professor and Director of Molecular Biology
and Genetics, was a 2009 recipient of the Nobel Prize in Physiology or Medicine.
Greider was honored for her pioneering research of telomeres, tiny caps that protect
the ends of chromosomes. Greider discovered telomerase, an enzyme that restores telomeres and protects them from damage. The connection of telomeres and telomerase to cancer development is a major area of research.


David Cosgrove, MBBCh, assistant professor of oncology, has joined the Gastrointestinal Cancer Program and will be developing a clinical research program for liver cancer.


Hans Hammers, M.D., Ph.D., assistant professor of oncology, will be working to decipher the factors associated with antiangiogenesis treatment (treatments that cut off the blood supply to tumors) resistance and is developing several clinical trials for prostate
and kidney cancers.


Robert S. Miller, M.D., F.A.C.P., has joined the Kimmel Cancer Center as a clinical associate at the Green Spring location where he will be treating patients with breast cancer.


As a new member of the hematologic malignancies program, Keith Pratz, M.D., assistant professor of oncology, will be developing a pharmacologybased clinical investigation program for acute leukemia and is designing clinical studies of new, molecularlytargeted
agents for adults with treatment- resistant leukemia.


A national expert on long term effects of cancer therapy, Kathryn Ruble, N.P., Ph.D., instructor in oncology and nurse practitioner, will further develop research projects related to these late effects and cancer survivorship.


Margaret Showel, M.D., has joined the hematologic malignancies program as an instructor in oncology. She will focus on the biology of leukemia, with a particular focus on cancer stem cells.


Stephanie Terezakis, M.D., has joined the Department of Radiation Oncology and Molecular Radiation Sciences to lead the pediatric radiation oncology program She also will join the sarcoma program and lead a study on the role of PET/CT radiation treatment
planning for patients with lymphoma.


The Department of Radiation Oncology and Molecular Radiation Sciences welcomes Phuoc Tran, M.D., Ph.D., assistant professor. He will focus on the treatment of genitourinary malignancies.


Lei Zheng, M.D., Ph.D., assistant professor of oncology, will be developing
multidisciplinary and adjuvant therapies for patients with pancreatic cancer.


Hao Wang, Ph.D., assistant professor in oncology, has joined the Biostatistics
Program to manage unusual data types related to cancer research and help clinical investigators with clinical trial and biomarker development and epidemiologic
research.

Related Content
 
 
 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer